Email page PDF view Print view Email Alert Social Media Sharing

Press Release

Conditions of Growth, Economic Analysis - Research Report on TCF Financial Corporation and Edwards Lifesciences Corp

Company Release - 4/26/2012 9:00 AM ET

HONG KONG -- (Marketwire) -- 04/26/12 -- Today, introduced research coverage of TCF Financial Corporation (NYSE: TCB) and Edwards Lifesciences Corp (NYSE: EW). Full research reports are available to readers at:

Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experienced in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Equity Leader has decided to cover TCF Financial Corporation for its current position within the financial industry. TCF Financial Corporation (TCF) is a national bank holding company. TCF's principal subsidiary is TCF National Bank (TCF Bank). TCF Bank operates bank branches in Minnesota, Illinois, Michigan, Colorado, Wisconsin, Indiana, Arizona and South Dakota. TCF's focus is on the delivery of retail and commercial banking products in markets served by TCF Bank. A copy of this report detailing TCF Financial Corporation (NYSE: TCB) is available at:

Equity Leader is also taking note of Edwards Lifesciences Corp for its changing role within the healthcare industry. Edwards Lifesciences Corporation (Edwards Lifesciences) is engaged in the science of heart valves and hemodynamic monitoring. The products and technologies provided by Edwards Lifesciences to treat advanced cardiovascular disease or critically ill patients are categorized into four main areas: Heart Valve Therapy; Critical Care; Cardiac Surgery Systems, and Vascular. To download free research on Edwards Lifesciences Corp (NYSE: EW) investors may visit:

About Equity Leader
Whether you are a first time investor or seasoned market professional, Equity Leader provides the resources necessary to simplify your research process. Our focus has always been to empower investors with the information they need to make their own investment decisions.


Michael Westbrook
Email Contact

Source: Equity Leader Inc.

The information that is on or available through this site speaks only as of the particular date or dates of that information. We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for inaccuracies or omissions in that information or for actions taken in reliance on that information. TCF Financial Corporation does not undertake an obligation, and disclaims any duty, to update any of the information on or available through this site.